Francesco Paolo Cantatore

Francesco Paolo Cantatore

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2013 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ANAnna Neve
Anna Neve
ACAddolorata Corrado
Addolorata Corrado
FCFrancesco Paolo Cantatore
Francesco Paolo Cantatore

1 December 2010 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
ANAnna Neve
Anna Neve
ACAddolorata Corrado
Addolorata Corrado
FCFrancesco Paolo Cantatore
Francesco Paolo Cantatore

30 May 2015 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
AKAlexandra Karystinou
Alexandra Karystinou
ARAnke J Roelofs
Anke J Roelofs
ANAnna Neve
Anna Neve
FCFrancesco Paolo Cantatore
Francesco Paolo Cantatore
HWHenning Wackerhage
Henning Wackerhage
CBCosimo De Bari
Cosimo De Bari
Introduction: The control of differentiation of mesenchymal stromal/stem cells (MSCs) is crucial for tissue engineering strategies employing MSCs. The purpose of this study was to investigate whether the transcriptional co-factor Yes-associated protein (YAP) regulates chondrogenic differentiation of MSCs. Methods: Expression of total YAP, its paralogue transcriptional co-activator with PDZ-binding motif (TAZ), and individual YAP transcript variants during in vitro chondrogenesis of human MSCs was determined by quantitative reverse transcription polymerase chain reaction (RT-PCR). YAP expression was confirmed by western blotting. To determine the effect of high YAP activity on chondrogenesis, C3H10T1/2 MSC-like cells were transduced with human (h)YAP and treated in micromass with bone morphogenetic protein-2 (BMP-2). Chondrogenic differentiation was assessed by alcian blue staining and expression of chondrocyte-lineage genes. BMP signalling was determined by detection of pSmad1,5,8 by western blotting and expression of BMP target genes by quantitative RT-PCR. Finally, YAP and pYAP were detected in mouse embryo hindlimbs by immunohistochemistry. Results: YAP, but not TAZ, was downregulated during in vitro chondrogenesis of human MSCs. One of the YAP transcript variants, however, was upregulated in high-density micromass culture. Overexpression of hYAP in murine C3H10T1/2 MSCs inhibited chondrogenic differentiation. High YAP activity in these cells decreased Smad1,5,8 phosphorylation and expression of the BMP target genes Inhibitor of DNA binding/differentiation (Id)1, Id2 and Id3 in response to BMP-2. In developing mouse limbs, Yap was nuclear in the perichondrium while mostly phosphorylated and cytosolic in cells of the cartilage anlage, suggesting downregulation of Yap co-transcriptional activity during physiological chondrogenesis in vivo. Conclusions: Our findings indicate that YAP is a negative regulator of chondrogenic differentiation of MSCs. Downregulation of YAP is required for chondrogenesis through derepression of chondrogenic signalling. Therapeutic targeting of YAP to promote cartilage repair and prevent secondary osteoarthritis is an exciting prospect in rheumatology.

24 May 2017 in Journal of Cellular Physiology
Verified
Journal Article
Open access
PDF file
NMNicola Maruotti
Nicola Maruotti
ACAddolorata Corrado
Addolorata Corrado
FCFrancesco Paolo Cantatore
Francesco Paolo Cantatore
Even if osteoarthritis pathogenesis is still poorly understood, numerous evidences suggest that osteoblasts dysregulation plays a key role in osteoarthritis pathogenesis. An abnormal expression of OPG and RANKL has been described in osteoarthritis osteoblasts, which is responsible for abnormal bone remodeling and decreased mineralization. Alterations in genes expression are involved in dysregulation of osteoblast function, bone remodeling, and mineralization, leading to osteoarthritis development. Moreover, osteoblasts produce numerous transcription factors, growth factors, and other proteic molecules which are involved in osteoarthritis pathogenesis.

15 January 2010 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
NMNicola Maruotti
Nicola Maruotti
FCFrancesco Paolo Cantatore
Francesco Paolo Cantatore
Evidence of the role of vitamin D in the regulation of T and B cells, macrophages, dendritic cells, and keratinocytes continues to accumulate and provides a link between vitamin D and many autoimmune diseases, including Crohn’s disease, juvenile diabetes mellitus, multiple sclerosis, asthma, and rheumatoid arthritis. Considering the influence of vitamin D on the immune system, it may have potential as a treatment for immune-mediated diseases, even if additional research is required to better quantify dosage. But the biggest obstacle to its clinical use is its potent hypercalcemic effect. The calcium status of the host may influence the effect of vitamin D on immunity.

Verified
Journal Article
Open access
PDF file
DCDaniela Cici
Daniela Cici
Addolorata CorradoAddolorata Corrado
Addolorata Corrado
Cinzia RotondoCinzia Rotondo
Cinzia Rotondo
FCFrancesco Paolo Cantatore
Francesco Paolo Cantatore
The Wnt signaling pathway plays a key role in several biological processes, such as cellular proliferation and tissue regeneration, and its dysregulation is involved in the pathogenesis of many autoimmune diseases. Several evidences support its role especially in bone complications of rheumatic diseases. In Rheumatoid Arthritis (RA), the Wnt signaling is implicated in systemic and localized bone loss, while available data of its role in Spondyloarthritis (SpA) are conflicting. In the last few decades, the quality of life of rheumatic patients has been dramatically improved by biological therapy, targeting cytokines involved in the pathogenesis of these diseases like tumor necrosis factor (TNF)α, interleukin (IL)-1, IL-6, IL-17. In this review, we reviewed the role of Wnt signaling in RA and SpA, focusing on the effect of biological therapy on this pathway and its possible clinical implications.